Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Aug 5 · below the Ichimoku cloud · RSI 59 · MACD above its signal
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $20.5M | 0.03% | 958.52K | −5.8% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a USNA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | Armstrong Kathryn Michelle Ph.D.Officer | — | 1.2K | — |
| Jul 23, 2026 | Benedict PeterChief Technology Officer | — | 598 | — |
| Jul 22, 2026 | Fuller Gilbert ADirector | — | 1.6K | — |
| Jul 22, 2026 | Wood Timothy EDirector | — | 1.6K | — |
| Jul 22, 2026 | Fleming John TurmanDirector | — | 1.6K | — |
| Jul 22, 2026 | Ding XiaDirector | — | 1.6K | — |
| Jul 22, 2026 | Winssinger Frederic J.Director | — | 1.6K | — |
| Jul 22, 2026 | Nixon J ScottDirector | — | 1.6K | — |
| Jul 22, 2026 | Pelosi Peggie JDirector | — | 1.6K | — |
| Jun 15, 2026 | Neidig Brent LowellOfficer | Sale at price 19.45 per share. | 5K | $97.30K |
| Jun 14, 2026 | Neidig Brent LowellOfficer | Sale at price 20.00 - 20.15 per share. | 2.5K | $50.47K |
| Jun 7, 2026 | Jones Paul AOfficer | Sale at price 18.50 per share. | 5.6K | $102.88K |
| May 31, 2026 | Fleming John TurmanDirector | Sale at price 17.93 per share. | 2.5K | $43.93K |
| May 27, 2026 | Jones Paul AOfficer | Sale at price 18.95 per share. | 6.8K | $129.11K |
| May 26, 2026 | Iiekking G DouglasChief Financial Officer | Sale at price 18.75 per share. | 5.4K | $100.51K |
| May 21, 2026 | Fuller Gilbert ADirector | Sale at price 18.66 per share. | 1.1K | $19.73K |
| May 6, 2026 | Foukas JoshuaOfficer | Sale at price 19.82 per share. | 3.8K | $75.14K |
| Apr 22, 2026 | Fuller Gilbert ADirector | — | 1.1K | — |
| Apr 22, 2026 | Wood Timothy EDirector | — | 1.1K | — |
| Apr 22, 2026 | Fleming John TurmanDirector | — | 1.1K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 10.5 | -0.8 | -18.8 | 9.0 | -3.9 | 16.7 | 3.6 | -35.5 | 1.5 | 6.8 | −21.2% | ||
| 2025 | -9.3 | -9.1 | -8.9 | 4.2 | 6.3 | 2.2 | -3.7 | 8.6 | -13.7 | -23.2 | -6.1 | -1.1 | −45.3% |
| 2024 | -12.6 | 3.1 | 0.5 | -14.4 | 14.6 | -5.0 | -1.4 | -8.5 | -7.1 | -2.6 | 4.3 | -6.9 | −33.0% |
| 2023 | 9.8 | 4.0 | 3.5 | 5.5 | -8.6 | 3.9 | 3.0 | -1.0 | -8.8 | -22.3 | 3.8 | 13.4 | +0.8% |
| 2022 | -5.6 | -7.9 | -9.7 | -3.5 | -8.3 | 2.9 | -3.8 | -7.3 | -13.1 | -6.3 | 4.8 | -3.3 | −47.4% |
| 2021 | 7.3 | 17.3 | 0.6 | -7.8 | 17.5 | -3.1 | -7.0 | 1.8 | -5.0 | 5.3 | 2.7 | 1.5 | +31.3% |
| 2020 | -21.5 | 7.1 | -12.6 | 54.5 | -5.0 | -13.3 | 10.6 | -3.4 | -6.1 | 2.7 | -0.6 | 2.6 | −1.8% |
| 2019 | -0.5 | -15.9 | -14.9 | -0.5 | -15.2 | 12.2 | -14.3 | -0.1 | 0.6 | 8.4 | -0.7 | 6.7 | −33.3% |
| 2018 | 0.8 | 2.3 | 12.4 | 22.9 | 10.8 | -1.5 | 14.7 | -0.2 | -8.6 | -2.9 | 4.6 | -3.8 | +59.0% |
| 2017 | 1.8 | -6.8 | -0.8 | -1.3 | 13.3 | -0.5 | -10.9 | 3.7 | -2.5 | 13.9 | 9.1 | 3.3 | +21.0% |
| 2016 | -0.7 | -11.2 | 7.7 | -2.5 | 1.9 | -7.6 | 23.2 | -0.4 | 1.2 | -7.1 | -5.1 | 0.4 | −4.2% |
| 2015 | -4.4 | 2.0 | 11.1 | 2.4 | 12.6 | 6.7 | -8.8 | 17.5 | -8.5 | -4.1 | 4.2 | -4.6 | +24.5% |
| 2014 | -20.8 | 22.2 | 3.0 | -9.9 | 6.0 | 8.7 | -18.3 | 14.4 | 0.9 | 54.7 | -6.4 | -3.8 | +35.7% |
| 2013 | 7.7 | 24.9 | 9.1 | 16.7 | 24.2 | 3.3 | 14.1 | -8.1 | 14.3 | -21.4 | 7.2 | 3.4 | +129.5% |
| 2012 | 14.5 | 6.7 | 0.6 | 11.7 | -3.1 | 1.8 | 9.4 | 0.8 | 2.5 | -7.2 | -4.3 | -20.2 | +8.4% |
| 2011 | -12.7 | -8.2 | -0.9 | 8.1 | -21.2 | 6.4 | -12.6 | -5.9 | 6.8 | 25.8 | -1.3 | -11.0 | −30.1% |
| 2010 | -10.9 | -2.6 | 13.4 | 15.4 | 3.3 | -2.5 | 14.7 | 1.4 | -5.0 | 8.8 | -4.1 | 3.2 | +36.2% |
| 2009 | -32.2 | -13.7 | 11.6 | 6.9 | 10.9 | 12.1 | 12.2 | -5.5 | 8.2 | -15.5 | 11.3 | -0.6 | −6.8% |
| 2008 | 16.9 | -28.1 | -29.3 | -11.5 | 30.5 | 5.6 | 26.9 | 11.1 | 8.3 | -7.4 | -20.0 | 12.7 | −7.7% |
| 2007 | 2.7 | 9.4 | -19.3 | -15.0 | -2.4 | 15.1 | -9.8 | -5.6 | 14.9 | -6.7 | 2.1 | -11.0 | −28.2% |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Buy / hold / sell counts